Delivery Order SPE2DR25D2206-SPE2DR26F9NN6
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,079.84 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in a 100 ml bottle on January 23, 2026. This firm fixed-price delivery order, with completion scheduled for January 26, 2026, represents a small-value pharmaceutical procurement issued under a larger indefinite delivery contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through open...
- The Defense Logistics Agency awarded a $7,589.05 delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Visipaque 320 mg/ml infusion bottles (150ml). This is a firm fixed-price contract with an ultimate completion date of January 23, 2026, and represents a non-set-aside award issued under competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,475.92 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100ml bottles, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,553.25 to AmerisourceBergen Drug Corp for the supply of Visipaque 270 mg/ml in a 150 ml bottle, with an ultimate completion date of January 27, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $28,921.50 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL in 100 mL bottles. The contract employs firm fixed-price pricing with no set-aside designation, indicating full and open competition. The award was executed on January 26, 2026, with an ultimate completion date of January 27, 2026. Performance will be conducted at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,301.12 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units). This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract falls under...
- The Defense Logistics Agency awarded a delivery order valued at $11,396.08 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL in 100 mL bottles. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. Visipaque is a contrast medium used in medical imaging procedures, reflecting the critical role of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Visipaque 320 mg/mL infusion bottles (150 mL units) with a ceiling value of $1,753.42. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to be completed by November 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...